Medication info
Olmesartan Medoxomil 10 mg Tablets

Olmesartan Medoxomil 10 mg Tablets

Prescription medicationTabletOral
Ingredient · strength
Olmesartan Medoxomil›10mg / 1 tablet
Manufacturer / importer
JW Pharmaceutical Corporation
Appearance
White, round, film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201100793 · Approved 2011.02.21 · Insurance code 644913280

Summary

Main use
Treatment of essential hypertension
Who takes it
Adults · Children
Adult dose
<Adults> The recommended initial dose is 10mg once daily, with or without food. If blood pressure is not adequately controlled at this dose, increase to 20mg once daily. If additional blood pressure reduction is required, the dose may be increased up to a maximum of 40mg per day. The antihypertensive effect appears within 2 weeks after starting treatment and reaches its maximum effect at approximately 8 weeks. If blood pressure is not controlled with this drug alone, it may be administered concomitantly with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended to take the drug at the same time each day (e.g., in the morning), if possible. For patients who may have intravascular volume depletion (e.g., patients receiving diuretics, particularly those with renal impairment), it is recommended to initiate treatment at a low dose while closely monitoring their condition. <Older adults> No dose adjustment is required when administering this drug to older adults aged 65 years or older. No overall differences in the efficacy or safety of this drug have been observed between older and younger patients; however, a more sensitive response in some older patients cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dose adjustment is required for patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, and the dose may be increased up to a maximum of 20mg per day. Use is not recommended in patients with severe hepatic impairment because there is no experience with its use in these patients.
Child dose
The safety and efficacy in children have not been established.

Ingredients

Manufacturer
JW Pharmaceutical Corporation

Efficacy & effects

Treatment of essential hypertension

  • Essential hypertension
View approved original text

Essential hypertension is a condition characterized by persistently high blood pressure, and this medication is used to manage blood pressure and prevent complications.

How to take

Adult dose

<Adults> The recommended initial dose is 10mg once daily, with or without food. If blood pressure is not adequately controlled at this dose, increase to 20mg once daily. If additional blood pressure reduction is required, the dose may be increased up to a maximum of 40mg per day. The antihypertensive effect appears within 2 weeks after starting treatment and reaches its maximum effect at approximately 8 weeks. If blood pressure is not controlled with this drug alone, it may be administered concomitantly with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended to take the drug at the same time each day (e.g., in the morning), if possible. For patients who may have intravascular volume depletion (e.g., patients receiving diuretics, particularly those with renal impairment), it is recommended to initiate treatment at a low dose while closely monitoring their condition. <Older adults> No dose adjustment is required when administering this drug to older adults aged 65 years or older. No overall differences in the efficacy or safety of this drug have been observed between older and younger patients; however, a more sensitive response in some older patients cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dose adjustment is required for patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, and the dose may be increased up to a maximum of 20mg per day. Use is not recommended in patients with severe hepatic impairment because there is no experience with its use in these patients.

Child dose

The safety and efficacy in children have not been established.

Precautions

This medication may cause serious harm to the fetus and newborn if taken during the second or third trimester of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Do not use if you are allergic to any of the components in this medication, or if you are pregnant or breastfeeding. Patients undergoing renal dialysis or those with severe liver dysfunction, as well as those with biliary obstruction, should not take this medication. Patients with lactose intolerance should avoid this medication due to the presence of lactose. Patients with certain diabetes conditions or moderate to severe renal function impairment should not take this medication in conjunction with certain other medications. Patients with decreased blood volume or salt may experience low blood pressure when starting this medication, so careful monitoring of their condition is necessary. Patients with severe heart failure or those with renal function that depends on the renin-angiotensin-aldosterone system should be cautious, as changes in renal function may occur. Patients with impaired renal function or kidney transplant recipients should have their renal function and electrolyte levels periodically checked with blood tests, and this medication is not recommended for patients with severe renal impairment. Patients with renal artery stenosis may also experience deterioration of renal function when taking this medication, so caution is advised. This drug can increase serum potassium levels, and patients with heart failure or renal impairment should have their potassium levels regularly monitored. Patients with aortic or mitral stenosis, or obstructive heart disease should be cautious, as blood pressure lowering effects may worsen their symptoms. Patients with primary aldosteronism may not respond well to this medication, so it is not recommended for them. As blood pressure may drop, dizziness may occur, so it is advised to avoid driving or operating hazardous machinery. This medication may be less effective in lowering blood pressure in Black patients compared to other races. During treatment with this medication, mild side effects such as dizziness, headache, dyspepsia may occur, and rarely, angioedema with swelling of the face or throat may occur. Liver function anomalies have been reported rarely, so monitoring liver health is advisable. This medication can interact with other drugs, so caution is needed when used together with potassium-sparing diuretics, potassium supplements, lithium, non-steroidal anti-inflammatory drugs, etc. Diabetic patients or those with decreased renal function are particularly advised to avoid the combination of this medication with certain other drugs. If taken during pregnancy, it may cause serious harm to the fetus, so it should be discontinued immediately upon learning of the pregnancy, and fetal status should be monitored regularly if needed. Breastfeeding women should discontinue breastfeeding or the medication, as this drug may be passed into breast milk. Safety has not been established for use in children, so it is advised not to use this medication in pediatric populations. Elderly patients may have an increased concentration of the drug in the body, so more careful observation is needed during administration. Overdose may cause symptoms of low blood pressure or cardiac arrhythmias, requiring immediate treatment.

Side effects

  • Dizziness
  • low back pain
  • bronchitis
  • increased creatine phosphokinase
  • diarrhea
  • headache
  • hematuria
  • hyperglycemia
  • hypertriglyceridemia
  • influenza-like symptoms
Show 39 more
  • pharyngitis
  • rhinitis
  • sinusitis
  • cough
  • chest pain
  • peripheral edema
  • vertigo
  • abdominal pain
  • indigestion
  • gastroenteritis
  • nausea
  • palpitations
  • hypercholesterolemia
  • hyperlipidemia
  • hyperuricemia
  • arthralgia
  • arthritis
  • myalgia
  • rash
  • facial edema
  • weakness
  • vascular edema
  • anaphylactic reaction
  • vomiting
  • chronic malabsorption syndrome
  • intestinal vascular edema
  • rhabdomyolysis
  • hyperkalemia
  • acute renal failure
  • elevated blood creatinine
  • hair loss
  • pruritus
  • urticaria
  • autoimmune hepatitis
  • headache
  • elevated blood pressure
  • epistaxis
  • asthma
  • position-related dizziness

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly closed container to protect it from air or moisture. Room temperature should be maintained between 1 and 25 degrees Celsius to help preserve the medication's effectiveness and prevent degradation.

Appearance and packaging

Appearance

White, round, film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.